Form 8-K - Current report:
SEC Accession No. 0000950170-23-027975
Filing Date
2023-06-14
Accepted
2023-06-14 16:31:03
Documents
12
Period of Report
2023-06-08
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K stro-20230608.htm   iXBRL 8-K 100077
  Complete submission text file 0000950170-23-027975.txt   220730

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20230608.xsd EX-101.SCH 2464
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20230608_lab.xml EX-101.LAB 13654
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20230608_pre.xml EX-101.PRE 11050
6 EXTRACTED XBRL INSTANCE DOCUMENT stro-20230608_htm.xml XML 4752
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 231014537
SIC: 2836 Biological Products, (No Diagnostic Substances)